These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34502261)

  • 21. Zfp206, Oct4, and Sox2 are integrated components of a transcriptional regulatory network in embryonic stem cells.
    Yu HB; Kunarso G; Hong FH; Stanton LW
    J Biol Chem; 2009 Nov; 284(45):31327-35. PubMed ID: 19740739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer.
    Stolzenburg S; Rots MG; Beltran AS; Rivenbark AG; Yuan X; Qian H; Strahl BD; Blancafort P
    Nucleic Acids Res; 2012 Aug; 40(14):6725-40. PubMed ID: 22561374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleosome allostery in pioneer transcription factor binding.
    Tan C; Takada S
    Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20586-20596. PubMed ID: 32778600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
    Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
    Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PARP1 poly(ADP-ribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation.
    Gao F; Kwon SW; Zhao Y; Jin Y
    J Biol Chem; 2009 Aug; 284(33):22263-22273. PubMed ID: 19531481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of Sox17 into a pluripotency reprogramming factor by reengineering its association with Oct4 on DNA.
    Jauch R; Aksoy I; Hutchins AP; Ng CK; Tian XF; Chen J; Palasingam P; Robson P; Stanton LW; Kolatkar PR
    Stem Cells; 2011 Jun; 29(6):940-51. PubMed ID: 21472822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
    Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
    J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis for nuclear import selectivity of pioneer transcription factor SOX2.
    Jagga B; Edwards M; Pagin M; Wagstaff KM; Aragão D; Roman N; Nanson JD; Raidal SR; Dominado N; Stewart M; Jans DA; Hime GR; Nicolis SK; Basler CF; Forwood JK
    Nat Commun; 2021 Jan; 12(1):28. PubMed ID: 33397924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous targeted inhibition of Sox2-Oct4 transcription factors using decoy oligodeoxynucleotides to repress stemness properties in mouse embryonic stem cells.
    Johari B; Zargan J
    Cell Biol Int; 2017 Dec; 41(12):1335-1344. PubMed ID: 28833847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel AKT phosphorylation sites identified in the pluripotency factors OCT4, SOX2 and KLF4.
    Malak PN; Dannenmann B; Hirth A; Rothfuss OC; Schulze-Osthoff K
    Cell Cycle; 2015; 14(23):3748-54. PubMed ID: 26654770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays.
    Chakravarthy H; Boer B; Desler M; Mallanna SK; McKeithan TW; Rizzino A
    J Cell Physiol; 2008 Sep; 216(3):651-62. PubMed ID: 18366076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation.
    Weber FA; Bartolomei G; Hottiger MO; Cinelli P
    Stem Cells; 2013 Nov; 31(11):2364-73. PubMed ID: 23939864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
    Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
    Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sox2 is essential for formation of trophectoderm in the preimplantation embryo.
    Keramari M; Razavi J; Ingman KA; Patsch C; Edenhofer F; Ward CM; Kimber SJ
    PLoS One; 2010 Nov; 5(11):e13952. PubMed ID: 21103067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.
    Watanabe H; Ma Q; Peng S; Adelmant G; Swain D; Song W; Fox C; Francis JM; Pedamallu CS; DeLuca DS; Brooks AN; Wang S; Que J; Rustgi AK; Wong KK; Ligon KL; Liu XS; Marto JA; Meyerson M; Bass AJ
    J Clin Invest; 2014 Apr; 124(4):1636-45. PubMed ID: 24590290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 38. Transcriptional regulation of nanog by OCT4 and SOX2.
    Rodda DJ; Chew JL; Lim LH; Loh YH; Wang B; Ng HH; Robson P
    J Biol Chem; 2005 Jul; 280(26):24731-7. PubMed ID: 15860457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interplay between minor and major groove-binding transcription factors Sox2 and Oct1 in translocation on DNA studied by paramagnetic and diamagnetic NMR.
    Takayama Y; Clore GM
    J Biol Chem; 2012 Apr; 287(18):14349-63. PubMed ID: 22396547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
    Lengerke C; Fehm T; Kurth R; Neubauer H; Scheble V; Müller F; Schneider F; Petersen K; Wallwiener D; Kanz L; Fend F; Perner S; Bareiss PM; Staebler A
    BMC Cancer; 2011 Jan; 11():42. PubMed ID: 21276239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.